| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9004599 | Biomedicine & Pharmacotherapy | 2005 | 4 Pages |
Abstract
Our data suggest that COX-2 methylation is associated with good prognostic factors in breast cancer patients. COX-2 promoter methylation may be one of the mechanisms by which tumor cells regulate COX-2 expression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L.W.C. Chow, L. Zhu, W.T.Y. Loo, E.L.H. Lui,